as on January 21, 2026 at 8:40 pm IST
Day's Low
Day's High
12.39%
Downside
3.91%
Upside
52 Week's Low
52 Week's High
77.17%
Downside
6.30%
Upside
Check Aclaris Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$283.9M
EPS (TTM)
-0.496
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.42
Industry PE ratio
-1.6651931330472103
PEG Ratio
-0.13
EBITDA
-65.7M
Revenue (TTM)
15.7M
Profit Margin
0.00%
Return On Equity TTM
-113.23%
Track how Aclaris Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aclaris Therapeutics Inc in the last 5 years
Lowest (-15.56x)
June 30, 2021
Industry (-1.67x)
January 21, 2026
Today (-1.42x)
January 21, 2026
Highest (-0.99x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.42x
Compare market cap, revenue, PE, and other key metrics of Aclaris Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $283.9M | -75.44% | -1.42 | 0.00% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
The Aclaris Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aclaris Therapeutics Inc investment value today
Current value as on today
₹1,82,956
Returns
₹82,956
(+82.96%)
Returns from Aclaris Therapeutics Inc Stock
₹76,923 (+76.92%)
Dollar Returns*
₹6,033 (+6.03%)
Based on 15 analysts
40.00%
Buy
60.00%
Hold
0.00%
Sell
Based on 15 analysts, 60% of analysts recommend a 'HOLD' rating for Aclaris Therapeutics Inc. Average target price of $7.67
Get share price movements and forecasts by analysts on Aclaris Therapeutics Inc.
What analysts predicted
40.03%UPSIDE
Target Price
$7.67
Current Price
$4.6
Analyzed by
15 Analysts
Target
$7.67
Aclaris Therapeutics Inc target price $7.67, a slight upside of 40.03% compared to current price of $4.6. According to 15 analysts rating.
Search interest for Aclaris Therapeutics Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -15.42M → -14.61M (in $), with an average increase of 5.6% per quarter
Price Rise
![]()
In the last 7 days, ACRS stock has moved up by 61.7%
Best in 1 Year
![]()
In the last 1 year, ACRS has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 1.45M → 3.29M (in $), with an average increase of 32.1% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 98.9%
| Organisation | Aclaris Therapeutics Inc |
| Headquarters | 701 Lee Road, Wayne, PA, United States, 19087 |
| Industry | Health Technology |
| CEO | Dr. Neal S. Walker D.O., M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Hugh M. Davis Ph.D. | President, COO & Director |
Dr. Roland Kolbeck Ph.D. | Chief Scientific Officer |
Mr. William C. Roberts | Senior VP of Corporate Communications & Investor Relations |
Mr. James Loerop | Chief Business Officer |
Mr. Ajay Aggarwal M.B.A., M.D. | Senior Vice President of Clinical Development |
Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
Mr. Kevin Balthaser | Chief Financial Officer |
Mr. Matthew Rothman J.D. | General Counsel & Corporate Secretary |
Dr. Jon Jacobsen Ph.D. | Senior Vice President of Chemistry |
Mr. Steve Tucker | Executive Vice President of Project Leadership |
Aclaris Therapeutics Inc share price today is $4.6 as on . Aclaris Therapeutics Inc share today touched a day high of $4.78 and a low of $4.03.
Aclaris Therapeutics Inc share touched a 52 week high of $4.89 on and a 52 week low of $1.05 on . Aclaris Therapeutics Inc stock price today i.e. is trending at $4.6,which is 5.93% down from its 52 week high and 338.10% up from its 52 week low.
Aclaris Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Aclaris Therapeutics Inc (ACRS) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Aclaris Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aclaris Therapeutics Inc share’s latest price of $4.6 as on January 21, 2026 at 8:40 pm IST, you will get 2.1739 shares of Aclaris Therapeutics Inc. Learn more about
fractional shares .
Aclaris Therapeutics Inc stock has given -75.44% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?